Real-time enrollment status for this bronchiectasis clinical trial
Current Status
Recruiting
Checked: October 13, 2026 at 12:03 PM UTC
| NCT Number | NCT07201051 |
| Recruiting Status | Recruiting |
| Condition | Bronchiectasis |
| Phase | PHASE2 |
| Target Enrollment | 363 participants |
| Active Locations | 31 sites in the US |
| Sponsor | GlaxoSmithKline |
| Last Updated on CT.gov | August 12, 2026 (Aug 12, 2026) |
As of October 13, 2026: Clinical trial NCT07201051 is currently recruiting participants. This phase2 study for bronchiectasis is actively seeking new participants at 31 locations across the United States. The study is sponsored by GlaxoSmithKline. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07201051 is actively recruiting participants as of October 13, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 31 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07201051 was last updated Aug 12, 2026 (August 12, 2026). HelloStudys verifies this status automatically.